BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3665670)

  • 1. [Circulating immune complex of ovarian epithelial carcinoma and its clinical use].
    Cui H; Qian HN
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jul; 22(4):223-5, 253-4. PubMed ID: 3665670
    [No Abstract]   [Full Text] [Related]  

  • 2. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
    Qian HN; Feng J; Fu TY
    Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possibility of immunodiagnosis in ovarian cancer.
    Chin Med J (Engl); 1978 May; 4(3):185-90. PubMed ID: 98299
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian cancer: immunologic diagnosis and therapy.
    Barber HR; Dorsett B
    Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
    Rao GS; Hanjani P
    Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary.
    Hill R; Daunter B; Khoo SK; Mackay EV
    Mol Immunol; 1981 Jul; 18(7):647-53. PubMed ID: 7300840
    [No Abstract]   [Full Text] [Related]  

  • 7. Ovarian tumor antigens: preliminary histological investigation.
    Daunter B; Jaa-Kwee D; Miklosi S; Wright G
    Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of tumour-associated immunoglobulins from ascitic fluid.
    Hill R; Daunter B; Khoo SK; MacKay EV
    Br J Cancer; 1978 Jul; 38(1):154-7. PubMed ID: 687514
    [No Abstract]   [Full Text] [Related]  

  • 9. Types of immune complexes in the ascitic fluid of women with carcinoma of the ovary.
    Silburn PA; Khoo SK; Daunter B; Hill R; Roberts TK; Mackay EV
    Int Arch Allergy Appl Immunol; 1983; 71(3):219-23. PubMed ID: 6602096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sequential determination of circulating immune complexes in ovarian tumors].
    Beaufort F; Auner H; Lahousen M
    Wien Med Wochenschr; 1986 Jul; 136(13):317-22. PubMed ID: 3765649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer.
    Silburn PA; Khoo SK; Hill R; Daunter B; Mackay EV
    Diagn Immunol; 1984; 2(1):30-5. PubMed ID: 6209058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polysaccharide complex of human ovarian cancer studied by the microprecipitation reaction].
    Gorodilova VV; Ul'chenko VM
    Vopr Onkol; 1980; 26(11):62-5. PubMed ID: 7456427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complexes in ovarian cancer: association between IgM class complexes and antinuclear autoantibodies in ascitic fluid.
    Silburn PA; Neil JC; Khoo SK; Daunter B; Hill R; Collins RJ; Mackay EV
    Int Arch Allergy Appl Immunol; 1984; 74(1):63-6. PubMed ID: 6608501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
    Zhou JW; Cheng Q; Xie X; Chen HZ; Ye DF; Lu WG
    Ai Zheng; 2004 May; 23(5):573-6. PubMed ID: 15142457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovarian carcinoma-associated antigen isolated from peritoneal effusions in clinical diagnosis].
    Qian HN
    Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):242-6. PubMed ID: 6426896
    [No Abstract]   [Full Text] [Related]  

  • 16. [Production of polyclonal antibody against ovarian epithelial carcinoma and its use in tumor localization].
    Hu XF
    Zhonghua Fu Chan Ke Za Zhi; 1988 Jan; 23(1):31-4, 61. PubMed ID: 3383693
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes.
    Melioli G; Ferrari I; Casartelli G; Ragni N
    Gynecol Oncol; 1993 Mar; 48(3):301-7. PubMed ID: 8462898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
    Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
    Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of tumor-specific antibodies from effusions of ovarian carcinomas.
    Dorsett BH; Ioachim HL; Stolbach L; Walker J; Barber HR
    Int J Cancer; 1975 Nov; 16(5):779-86. PubMed ID: 1184243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.